| ID | 69069 |
| FullText URL | |
| Author |
Ahn, Myung-Ju
Samsung Medical Center, Sungkyunkwan University School of Medicine
Cho, Byoung Chul
Yonsei Cancer Center, Yonsei University College of Medicine
Felip, Enriqueta
Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology
Korantzis, Ippokratis
Department of Medical Oncology, Saint Loukas Hospital
Ohashi, Kadoaki
Department of Respiratory Medicine, Okayama University Hospital
Majem, Margarita
Hospital de la Santa Creu i Sant Pau
Juan-Vidal, Oscar
Handzhiev, Sabin
Klinische Abteilung für Pneumologie, Universitätsklinikum Krems
Izumi, Hiroki
Department of Thoracic Oncology, National Cancer Center Hospital East
Lee, Jong-Seok
Seoul National University Bundang Hospital
Dziadziuszko, Rafal
Department of Oncology and Radiotherapy and Early Phase Clinical Trials Center, Medical University of Gdansk
Wolf, Jürgen
Department of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne
Blackhall, Fiona
Christie NHS Foundation Trust and University of Manchester
Reck, Martin
Lungen Clinic, Airway Research Center North, German Center for Lung Research
Alvarez, Jean Bustamante
West Virginia University Health Sciences Center
Hummel, Horst-Dieter
Translational Oncology–Early Clinical Trial Unit, Comprehensive Cancer Center Mainfranken and Bavarian Cancer Research Center, Universitätsklinikum Würzburg
Dingemans, Anne-Marie C.
Department of Pulmonary Medicine, Erasmus MC Cancer Institute
Sands, Jacob
Dana–Farber Cancer Institute, Harvard Medical School
Akamatsu, Hiroaki
Wakayama Medical University Hospital
Owonikoko, Taofeek K.
Division of Hematology–Oncology, Hillman Cancer Center, University of Pittsburgh Medical Center
Ramalingam, Suresh S.
Winship Cancer Institute of Emory University
Borghaei, Hossein
Fox Chase Cancer Center
Johnson, Melissa L.
Sarah Cannon Research Institute at Tennessee Oncology
Huang, Shuang
Amgen
Mukherjee, Sujoy
Amgen
Minocha, Mukul
Amgen
Jiang, Tony
Amgen
Martinez, Pablo
Amgen
Anderson, Erik S.
Amgen
Paz-Ares, Luis
Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Complutense University and Ciberonc
|
| Keywords | Clinical trials
DeLLphi-301
DLL3
Immunotherapy
SCLC
Small cell lung cancer
T cell
Tarlatamab
|
| Published Date | 2024-11-12
|
| Publication Title |
Future Oncology
|
| Volume | volume20
|
| Issue | issue40
|
| Publisher | Informa UK Limited
|
| Start Page | 3355-
|
| End Page | 3364
|
| ISSN | 1479-6694
|
| NCID | AA1206226X
|
| Content Type |
Journal Article
|
| language |
English
|
| OAI-PMH Set |
岡山大学
|
| Copyright Holders | © 2024 The Author(s).
|
| File Version | publisher
|
| PubMed ID | |
| DOI | |
| Web of Science KeyUT | |
| Related Url | isVersionOf https://doi.org/10.1080/14796694.2024.2402152
|
| License | https://creativecommons.org/licenses/by-nc-nd/4.0/
|
| Citation | Myung-Ju Ahn, Byoung Chul Cho, Enriqueta Felip, Ippokratis Korantzis, Kadoaki Ohashi, Margarita Majem, Oscar Juan-Vidal, Sabin Handzhiev, Hiroki Izumi, Jong-Seok Lee, Rafal Dziadziuszko, Jürgen Wolf, Fiona Blackhall, Martin Reck, Jean Bustamante Alvarez, Horst-Dieter Hummel, Anne-Marie C. Dingemans, Jacob Sands, Hiroaki Akamatsu, Taofeek K. Owonikoko, Suresh S. Ramalingam, Hossein Borghaei, Melissa L. Johnson, Shuang Huang, Sujoy Mukherjee, Mukul Minocha, Tony Jiang, Pablo Martinez, Erik S. Anderson & Luis Paz-Ares (2024) Plain language summary: tarlatamab for patients with previously treated small cell lung cancer, Future Oncology, 20:40, 3355-3364, DOI: 10.1080/14796694.2024.2402152
|
